SCIENTIFIC AND INFORMATION-ANALYTICAL MAGAZINE

ISSN 1024-6177 (Print), ISSN 2618-9615 (Online)

Medical Radiology and Radiation Safety. 2015. Vol. 60. No. 6. P. 48-53

REVIEW

I.A. Znamenskiy, A.K. Kondakov, A.V. Grechko

Positron Emission Tomography with Oxygen-15 in Neurology. Part 1. Basic and Historical Review

Federal State Budgetary Scientific Institution «Hospital for incurable patients - the Scientific and Medical Rehabilitation Center», Moscow, Russia, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

ABSTRACT

Purpose: A historical review of emergent technologies and the development of positron emission tomography with radiopharmaceuticals based on oxygen-15 along with its application in contemporaneity.

Material and methods: The article presents a review of sources selected from international bibliographic databases.

Results: It is shown that positron-emission tomography with radiopharmaceuticals based on oxygen-15 originated from studies of brain perfusion in the early 1960th. With positron emission tomography invented in mid-1970s, these studies lead to deep exploration of pathophysiologic basis of a number of brain diseases, mainly ischemic type diseases. The article presents basic methods of positron-emission tomography with labelled water and gaseous radiopharmaceuticals based on oxygen-15.

Conclusion: Positron-emission tomography with radiopharmaceuticals based on oxygen-15 in contemporaneity is the only one direct validated method of measurement of a number of quantities characterizing the perfusion and functional capacity of the brain. The need to implement a large number of expensive technical measures prevents the wide application of this method.

Key words: positron emission tomography, oxygen-15, perfusion, brain

REFERENCES

  1. Saha G.B. Basics of PET Imaging: Physics, Chemistry, and Regulations. In: “Basics of PET Imaging: Physics, Chemistry, and Regulations”. 2010. P. 97-116.
  2. Ter-Pogossian M.M., Phelps M.E., Hoffman E.J. et al. A positron-emission transaxial tomograph for nuclear imaging (PETT). Radiology. 1975. Vol. 114. No. 1. P. 89-98.
  3. Ter-Pogossian M.M., Powers W.E. The use of radioactive oxygen-15 in the determination of oxygen content in malignant neoplasms. Radioisotopes in Scientific Research. Vol 3: Proc. 1st UNESCO Internat. Conf. Paris: Pergamon. 1957. 625 p.
  4. Dyson N.A., Sinclair J.D., West J.B. A comparison of the uptakes of oxygen-15 and oxygen-16 in the lung. J. Physiol. 1960. Vol. 152. P. 325-336.
  5. Ter-Pogossian M., Spratt J.S., Rudman S. et al. Radioactive oxygen-15 in study of kinetics of oxygen of respiration. Amer. J. Physiol. 1961. Vol. 201. P. 582-586.
  6. Spratt J.S., Ter-Pogossian M., Rudman S. et al. Radioactive oxygen-15 in the tracer study of oxygen transport. Surg. Forum, 1961. Vol. 12. P. 7-9.
  7. Asakura T., Yoshikawa H., Iio M. et al. Comparison of the affinity of oxygen-15 and oxygen 16 to hemoglobin. J. Appl. 1966. Vol. 21. No. 3. P. 1091-1093.
  8. Ter-Pogossian M.M., Taveras J.M., Davis D.O. A study of regional cerebral oxygen supply and utilization by means of radioactive oxygen-15. Recent Advances in the Study of Circulation. Ed. Taveras J.M., Fischgold H., Dilenge D. - Springfield: Charles C. Thomas. 1969. P. 156-174.
  9. Ter-Pogossian M.M., Eichling J.O., Davis D.O. et al. The measure in vivo of regional cerebral oxygen utilization by means of oxyhemoglobin labeled with radioactive oxygen-15. J. Clin. Invest. 1970. Vol. 49. No. 2. P. 381-391.
  10. Davis D.O., Ter-Pogossian M.P., Dichling J.O. et al. The determination of regional cerebral blood flow by means of water labelled with radioactive oxygen-15. Trans. Amer. Neurol. Assoc. 1969. Vol. 94. P. 244-245.
  11. Raichle M.E., Martin W.R., Herscovitch P. et al. Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation. J. Nucl. Med. 1983. Vol. 24. No. 9. P. 790-798.
  12. Mintun M.A., Raichle M.E., Martin W.R. et al. Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography. J. Nucl. Med. 1984. Vol. 25. No. 2. P. 177-187.
  13. Eichling J.O., Raichle M.E., Grubb R.L. et al. In vivo determination of cerebral blood volume with radioactive oxygen-15 in the monkey. Circ. Res. 1975. Vol. 37. No. 6. P. 707-714.
  14. Raichle M.E., Grubb R.L.J., Eichling J.O. et al. Measurement of brain oxygen utilization with radioactive oxygen-15: experimental verification. J.Appl. Physiol. 1976. Vol. 40. No. 4. P. 638-640.
  15. Baron J.-C., Jones T. Oxygen metabolism, oxygen extraction and positron emission tomography: Historical perspective and impact on basic and clinical neuroscience. Neuroimage. 2012. Vol. 61. No. 2. P. 492- 504.
  16. Jones T., Chesler D.A., Ter-Pogossian M.M. The continuous inhalation of oxygen-15 for assessing regional oxygen extraction in the brain of man. Brit. J. Radiol. 1976. Vol. 49. No. 580. P. 339-343.
  17. Baron J.C., Comar D., Bousser M.G. et al. Tomographic study in humans of blood flow and oxygen consumption of the brain by continuous inhalation of oxygen-15. Preliminary findings in cerebral ischemic accidents. Rev. Neurol. 1978. Vol. 134. No. 10. P. 545-556.
  18. Lenzi G.L., Jones T., McKenzie C.G. et al. Study of regional cerebral metabolism and blood flow relationships in man using the method of continuously inhaling oxygen-15 and oxygen-15 labelled carbon dioxide. J. Neurol. Psychiatry. 1978. Vol. 41. No. 1. P. 1-10.
  19. Burnham C.A., Brownell G.L. A multi-crystal positron camera. IEEE Trans. Nucl. Sci. 1972. Vol. 19. No. 3. P. 201-205.
  20. Lassen N.A. The luxury-perfusion syndrome and its possible relation to acute metabolic acidosis localized within the brain. Lancet (London, England). 1966. No. 7473. P. 1113-1115.
  21. Baron J.C., Bousser M.G., Rey A. et al. Reversal of focal “misery-perfusion syndrome” by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. A case study with 15O positron emission tomography. Stroke. 1981. Vol. 12. No. 4. P. 454-459.
  22. Cho I.-H., Hayashida K., Kume N. et al. Visualization of pressure-dependent luxury perfusion in a patient with subacute cerebral infarction. Ann. Med. 1998. Vol. 12. No. 4. P. 217-220.
  23. Lenzi G.L., Jones T., McKenzie C.G. et al. Study of regional cerebral metabolism and blood flow relationships in man using the method of continuously inhaling oxygen-15 and oxygen-15 labelled carbon dioxide. J. Neurol. Psychiatry. 1978. Vol. 41. No. 1. P. 1-10.
  24. Lenzi G.L., Jones T., McKenzie C.G. et al. Non-invasive regional study of chronic cerebrovascular disorders using the oxygen-15 inhalation technique. J. Neurol. Psychiatry. 1978. Vol. 41. No. 1. P. 11-17.
  25. Ackerman R.H., Correia J.A., Alpert N.M. et al. Positron imaging in ischemic stroke disease using compounds labeled with oxygen-15. Initial results of clinicophysiologic correlations. Arch.Neurol. 1981. Vol. 38. No. 9. P. 537-543.
  26. McKenzie C.G., Lenzi G.L., Jones T. et al. Radioactive oxygen 15O studies in cerebral neoplasms. J. R. Soc. Med. 1978. Vol. 71. No. 6. P. 417-425.
  27. Pinching A.J., Travers R.L., Hughes G.R. Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus. Lancet. 1978. No. 8070. P. 898-900.
  28. Lenzi G.L., Jones T., Reid J.L. et al. Regional impairment of cerebral oxidative metabolism in Parkinson’s disease. J. Neurol. Psychiatry. 1979. Vol. 42. No. 1. P. 59-62.
  29. Rhodes C.G., Lenzi G.L., Frackowiak R.S.J. Measurement of CBF and CMRO2 using the continuous inhalation of C15O2 and 15O2. Experiment validation using CO2 reactivity in the anaesthetised dog. J. Neurol. Sci. 1981. Vol. 50. No. 3. P. 381-389.
  30. Baron J., Steinling M., Tanaka T. Quantitative measurement of CBF, oxygen extraction fraction (OEF) and CMRO2 with the 15O continuous inhalation technique and positron. J. Cereb. Blood Flow Metab. 1981.
  31. Steinling M., Baron J.C., Maziere B. et al. Tomographic measurement of cerebral blood flow by the 68Ga-labelled-microsphere and continuous-C15O2- inhalation methods. Eur. J. Nucl. Med. 1985. Vol. 11. No. 1. P. 29-32.
  32. Kim E.E., Wong F.C.L. Protocol for PET Using 15O water or gases and 11C methionine. Clinical PET and PET/CT. Ed. Kim E.E., Lee M.-C., Inoue T. et al. New York: Springer. 2013. P. 398.
  33. Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007. Ann. ICRP. 2008. Vol. 38. No. 1-2. P. 1-197.
  34. Bigler R.E., Sgouros G. Biological analysis and dosimetry for 15O-labeled O2, CO2, and CO gases administered continuously by inhalation. J. Nucl. Med. 1983. Vol. 24. No. 5. P. 431-437.
  35. Bremmer J.P., van Berckel B.N.M., Persoon S. et al. Day-to-Day test-retest variability of CBF, CMRO2, and OEF Measurements Using Dynamic 15O PET Studies. Mol. Imaging Biol. 2010. Vol. 13. No. 4. P. 759-768.

For citation: Znamenskiy IA, Kondakov AK, Grechko AV. Positron Emission Tomography with Oxygen-15 in Neurology. Part 1. Basic and Historical Review. Medical Radiology and Radiation Safety. 2015;60(6):48-53. Russian.

PDF (RUS) Full-text article (in Russian)

© Журнал "Медицинская радиология и радиационная безопасность" 2020г.

Яндекс.Метрика

Наверх